YorkTest Laboratories Limited (YorkTest), Europe’s leading food intolerance (delayed food allergy) testing company, has been acquired by Ingemino Ltd., a newly established company formed by successful entrepreneurs Keith Tozzi and Fiona Begley. Financial details will remain confidential.
YorkTest manufactures and markets a number of self-test services of laboratory analyzed diagnostic home health tests direct to consumers, to medical laboratories and to practitioners both in the UK and in over 50 countries around the world. The company’s aim is to empower people with informed, personal insights to enable them to change their diet and improve their health. Combined with increasing media coverage and powerful endorsements from key opinion leaders, including world renowned marathon runner Paula Ratcliffe, YorkTest has seen sustained profitable growth over the past few years. Tom Hardman, YorkTest’s Managing Director, will join the board of Ingemino.
Ingemino Ltd. is a newly formed company that has been established to acquire, develop and grow a series of key businesses in the testing arena. The focus of the business is laboratory-based testing solutions and the key objective is to develop Ingemino into a world-class organization through a combination of complementary acquisitions and aggressive organic growth. The acquisition was supported by Close Brothers Private Equity (CPBE Capital).
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
John Graham, the retiring Chairman and majority shareholder, commented on the closing of the transaction: “I wanted to express my personal thanks to you for all your efforts and achieving a successful sale of YorkTest. I never knew how stressful and difficult the sale process could be. I really do appreciate you finding a good deal in quite difficult circumstances.”
Lord Howard Leigh
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.